Literature DB >> 26893309

Eccentric Exercise Versus Eccentric Exercise and Soft Tissue Treatment (Astym) in the Management of Insertional Achilles Tendinopathy.

Joshua R McCormack1,2, Frank B Underwood1,3, Emily J Slaven4, Thomas A Cappaert1.   

Abstract

BACKGROUND: Eccentric exercise is commonly used in the management of Achilles tendinopathy (AT) but its effectiveness for insertional AT has been questioned. Soft tissue treatment (Astym) combined with eccentric exercise could result in better outcomes than eccentric exercise alone. HYPOTHESIS: Soft tissue treatment (Astym) plus eccentric exercise will be more effective than eccentric exercise alone for subjects with insertional AT. STUDY
DESIGN: Prospective randomized controlled trial. LEVEL OF EVIDENCE: Level 2.
METHODS: Sixteen subjects were randomly assigned to either a soft tissue treatment (Astym) and eccentric exercise group or an eccentric exercise-only group. Intervention was completed over a 12-week period, with outcomes assessed at baseline, 4, 8, 12, 26, and 52 weeks. Outcomes included the Victorian Institute of Sport Assessment Achilles-Specific Questionnaire (VISA-A), the numeric pain rating scale (NPRS), and the global rating of change (GROC).
RESULTS: Significantly greater improvements on the VISA-A were noted in the soft tissue treatment (Astym) group over the 12-week intervention period, and these differences were maintained at the 26- and 52-week follow-ups. Both groups experienced a similar statistically significant improvement in pain over the short and long term. A significantly greater number of subjects in the soft tissue treatment (Astym) group achieved a successful outcome at 12 weeks.
CONCLUSION: Soft tissue treatment (Astym) plus eccentric exercise was more effective than eccentric exercise only at improving function during both short- and long-term follow-up periods. CLINICAL RELEVANCE: Soft tissue treatment (Astym) plus eccentric exercise appears to be a beneficial treatment program that clinicians should consider incorporating into the management of their patients with insertional AT.

Entities:  

Keywords:  Achilles; eccentrics; soft tissue treatment (Astym); tendinopathy

Mesh:

Year:  2016        PMID: 26893309      PMCID: PMC4981065          DOI: 10.1177/1941738116631498

Source DB:  PubMed          Journal:  Sports Health        ISSN: 1941-0921            Impact factor:   3.843


Achilles tendinopathy (AT) is a clinical syndrome characterized by pain, swelling, and impaired function.[41] It is the most common cause of posterior heel pain, and runners have the greatest risk of developing AT with a prevalence of 11% to 18%.[16,23,36] Whereas runners represent the group most likely to develop AT, it can also occur in other athletes and sedentary individuals.[21,22] Achilles tendinopathy is typically classified as either insertional or midportion based on the location of pain. Insertional AT causes pain at or near the point where the Achilles tendon attaches to the posterior calcaneus, while midportion AT causes pain 2 to 7 cm proximal to the calcaneal attachment.[41] Insertional AT is responsible for between 20% and 25% of cases.[8,13,19] Eccentric exercise is the most recommended conservative treatment in the management of AT.[1,23,29,30,39,40] The outcomes after treatment with eccentric exercise have varied significantly between insertional and midportion AT. For midportion AT, success rates have ranged from 56% to 89%.[9,33] For insertional AT, the results have been significantly less favorable with success rates between 28% and 32%.[9,32] Because of the poor outcomes associated with insertional AT and eccentric exercise, a modified eccentric protocol that eliminated loading into dorsiflexion was developed.[18] In 1 study with no control group, a 67% success rate was reported.[18] Soft tissue mobilization is a recommended treatment in the management of tendinopathies, though there is limited evidence supporting this approach.[11,20,28] Astym (Performance Dynamics) is a specialized soft tissue treatment that utilizes handheld instruments to transfer pressure and shear stress to underlying soft tissue.[7] Astym treatment may induce regeneration and remodeling of soft tissue through activation of fibroblasts by means of the endogenous release of cellular mediators and growth factors.[35] Increased fibroblast recruitment and activation as well as the production of fibronectin have followed Astym treatment in rat tendons, but this has not been studied in humans.[6,12,34] As soft tissue treatment (Astym) and eccentric exercise both appear to effect tendon healing, it seems possible that the combination of the 2 treatments may result in better outcomes than eccentric exercise alone.[24,25] A recent randomized controlled trial reported that Astym therapy, stretching, and eccentric exercise were more effective than stretching and eccentric exercise alone for subjects with lateral elbow tendinopathy.[35] Therefore, the purpose of this study was to compare the outcomes between eccentric exercise only and eccentric exercise plus soft tissue treatment (Astym) for subjects with insertional AT.

Methods

This study was approved by the institutional review boards at Rocky Mountain University of Health Professions and Indiana University Health Ball Memorial Hospital. All subjects signed an informed consent form prior to participation, and the rights of all subjects were protected. The study was registered at clinicaltrials.gov (NCT01988155).

Subjects

Sixteen subjects older than 18 years with insertional AT participated in this study. The following were the inclusion criteria: diagnosis of insertional AT with a primary complaint of posterior heel pain, symptom duration of at least 6 weeks, and a VISA-A score of ≤78. Insertional AT was clinically determined by the primary investigator (J.R.M.) using the following criteria: pain at or within 2 cm of the posterior calcaneal insertion of the Achilles tendon along with localized tenderness and a subjective report of decreased activity levels secondary to Achilles pain.[9,32] Exclusion criteria were: prior treatment with eccentric exercise or Astym for AT, anticoagulant medication, previous Achilles surgery on the involved side, bilateral symptoms, workers’ compensation or liability cases, peripheral neuropathy, pregnancy, lumbar radiculopathy, and inability to complete the required outcomes forms or comply with the recommended treatment regimen. Prior to the start of subject recruitment, an individual not involved with the study used a random number generator to assign subjects to a treatment group. Group assignments were then placed in sequentially numbered and sealed opaque envelopes. An envelope was opened only once the corresponding subject agreed to enter the study.

Outcomes

The primary outcome was the Victorian Institute of Sport Assessment Achilles-Specific Questionnaire (VISA-A).[31] The VISA-A is a self-administered questionnaire used to evaluate the severity of AT. It has previously been shown to be valid, reliable, and clinically relevant.[14,31] VISA-A scores can range from 0 to 100, with higher scores considered better. The secondary outcome was a self-administered 3-part numeric pain rating scale (NPRS). Subjects were asked to indicate their “worst pain” and “best pain” in the previous 24 hours in addition to their “current pain.” The average of all 3 was utilized as a subject’s score. The NPRS has been shown to be valid and reliable for individuals with musculoskeletal conditions.[2,17,26,37] A 15-point Global Rating of Change scale (GROC)[15] questionnaire was completed by subjects at the 12-week follow-up period. Subjects with scores of +5 or higher were considered to have experienced a successful outcome.[3-5,27,38]

Procedures

Baseline and demographic data including age, sex, duration of symptoms, height, weight, smoking status, presence of diabetes mellitus, and heel lift usage were collected. Initial scores on the NPRS and VISA-A were recorded at the first visit. Follow-up outcomes were obtained at 4, 8, and 12 weeks after initiation of treatment for the short-term portion of the study. Long-term outcomes were obtained at 26 and 52 weeks after the initiation of treatment. Subjects were given the option to complete and return their outcomes by mail or to come to the clinic to complete them in person.

Interventions

Subjects in both groups were instructed to perform the modified eccentric protocol (Figure 1).[18] Subjects performed 3 sets of 15 repetitions per session and performed 2 sessions per day for a total of 12 weeks. In the event that a subject was unable to complete 3 sets of 15 repetitions, the subject was instructed to start with a lower number of repetitions and/or sets (a minimum of 2 sets of 10) and progress to the full amount as able. Subjects in both groups were instructed to avoid activities such as running for at least the first 4 weeks of treatment, but they could resume activities as tolerated after 4 weeks.
Figure 1.

Eccentric exercise as performed in current study for a subject with right side insertional Achilles tendinopathy. Step 1: Perform heel raise with unaffected leg; step 2: Transfer weight to affected leg; step 3: Slowly lower heel of affected leg to floor.

Eccentric exercise as performed in current study for a subject with right side insertional Achilles tendinopathy. Step 1: Perform heel raise with unaffected leg; step 2: Transfer weight to affected leg; step 3: Slowly lower heel of affected leg to floor. In addition to performing the eccentric protocol, subjects in the soft tissue treatment (Astym) group were seen in the clinic 2 times per week for 12 visits. Soft tissue treatment (Astym) was performed per the foot, ankle, and knee protocol.[34] During each treatment session, a progression of instruments with decreasing areas of surface contact was used (Figures 2 and 3).[10,34] Each treatment session lasted approximately 20 to 30 minutes.
Figure 2.

Astym instruments.

Figure 3.

Astym treatment.

Astym instruments. Astym treatment. To control for the effect of regular contact with a therapist, subjects in the control group were contacted by telephone once per week to discuss their progress with the program, encourage compliance, and address any questions.

Statistical Analysis

For the purpose of a power analysis, the smallest reported minimal clinically important difference (MCID) on the VISA-A of 12 points[14] was selected to be the minimum between-group difference that would be considered significant. For subjects with insertional AT, the standard deviation in VISA-A scores after completion of an eccentric exercise program was 12 points.[32] An a priori power calculation using an alpha of 0.05, an effect size index of 1.0, and power of 0.90 was performed, and a total sample size of 12 was recommended. Statistical analyses were performed using SPSS Version 22.0 (IBM). Independent t tests (or chi-square tests for independence in the case of dichotomous data) were used to compare groups at baseline. Mixed-model (4 × 2) analyses of variance (ANOVAs) were used to analyze short-term VISA-A and NPRS scores. Correlation testing (Pearson for continuous variables and point-biserial for dichotomous variables) was performed to determine whether sex, body mass index, age, heel lift usage, or the presence of diabetes mellitus were significantly correlated with any of the dependent variables. The percentage of subjects in each group who achieved at least 1 MCID improvement on the VISA-A at 12 weeks and the percentage of subjects in each group who achieved a successful outcome at 12 weeks were compared using chi-square tests for independence. Additional mixed-model (3 × 2) ANOVAs, using 12 weeks as the baseline, were used to analyze long-term VISA-A and NPRS scores.

Results

Short-term Outcomes

Both groups were considered similar at baseline (Table 1). A total of 16 subjects were enrolled, and 15 subjects completed the short-term portion of the study (Figure 4). One subject was excluded from the study immediately after enrollment because he had previously received Astym for an earlier episode of AT. Of the remaining 15 subjects, 14 completed their outcomes at all of the required time points and were included in the final analysis. One subject in the exercise group completed only the baseline and 12-week outcomes so his or her data could not be included in the final ANOVA. However, an intention to treat analysis (ITT) was performed using the multiple imputation method for missing data in a separate ANOVA. None of the baseline criteria were significantly correlated with baseline to 12-week change scores on the VISA-A or NPRS. No adverse effects were noted in either group.
Table 1.

Baseline demographics and clinical characteristics of subjects

Exercise (n = 9)Astym (n = 7)P Value
Sex, M/F3/62/50.84
Age, y, mean (range)53.9 (42-69)53.3 (38-69)0.80
Duration, wk20.821.90.87
BMI, kg/m2, mean36.637.30.89
Heel lift users, n220.77
Smoker, n100.36
Diabetes, n210.69
VISA-A (SD)40.2 (17.3)36.6 (19.3)0.70
NPRS (SD)5.4 (2.3)4.6 (1.9)0.47

BMI, body mass index; F, female; M, male; NPRS, numeric pain rating scale; VISA-A, Victorian Institute of Sport Assessment Achilles-Specific Questionnaire.

Figure 4.

CONSORT (Consolidated Standards of Reporting Trials) flow diagram.

Baseline demographics and clinical characteristics of subjects BMI, body mass index; F, female; M, male; NPRS, numeric pain rating scale; VISA-A, Victorian Institute of Sport Assessment Achilles-Specific Questionnaire. CONSORT (Consolidated Standards of Reporting Trials) flow diagram.

Victorian Institute of Sport Assessment Achilles-Specific Questionnaire

There was a significant interaction effect with greater improvements (P = 0.02) seen in the soft tissue treatment (Astym) group on the VISA-A (Figure 5). The ITT analysis yielded similar results.
Figure 5.

Mean Victorian Institute of Sport Assessment Achilles-Specific Questionnaire (VISA-A) scores at baseline and each follow-up period.

Mean Victorian Institute of Sport Assessment Achilles-Specific Questionnaire (VISA-A) scores at baseline and each follow-up period. A significantly greater (P = 0.01) number of subjects in the soft tissue treatment (Astym) group (7/7, 100%) achieved at least 1 MCID improvement on the VISA-A at 12 weeks compared with the exercise group (3/8, 38%). For subjects receiving soft tissue treatment (Astym) and eccentric exercise, the number needed to treat (NNT) to prevent 1 subject from not achieving at least 1 MCID improvement was 2.

Numeric Pain Rating Scale

A significant main effect (P = 0.03) of time was found (Figure 6), but the between-group difference was not significant. The ITT analysis yielded similar results.
Figure 6.

Mean numeric pain rating scale (NPRS) scores at baseline and each follow-up period.

Mean numeric pain rating scale (NPRS) scores at baseline and each follow-up period.

Global Rating of Change

A significantly greater (P = 0.03) number of subjects in the soft tissue treatment (Astym) group (7/7, 100%) achieved a successful outcome at 12 weeks compared with the exercise group (4/8, 50%). For subjects receiving soft tissue treatment (Astym) and eccentric exercise, the NNT to prevent 1 subject from not achieving a successful outcome was 2.

Long-term Outcomes

At the 26- and 52-week follow-up periods, 12 subjects completed all of the required outcomes and were included in the final analyses. All 15 subjects provided at least partial data for the long-term follow-up periods and were included in the ITT analyses. A significant main effect for group was found (P < 0.01) in favor of the soft tissue treatment (Astym) group (Table 2). The ITT analysis yielded similar results.
Table 2.

VISA-A values at baseline and follow-up[]

Baseline4 wk8 wk12 wk26 wk52 wk
Exercise40.2 (26.7-53.7)42.7 (22.1-63.3)53 (28.3-77.7)51.5 (33.2-69.8)55.3 (38.4-72.2)67 (52.8-81.2)
Astym36.6 (18.8-54.5)62.6 (49.2-76.0)75.3 (62.4-88.3)81.9 (69.9-94.0)86 (70.0-102.0)90.7 (79.2-102.1)
P value0.70.070.07<0.01<0.01<0.01

VISA-A, Victorian Institute of Sport Assessment Achilles-Specific Questionnaire.

Data presented as score (95% CI).

VISA-A values at baseline and follow-up[] VISA-A, Victorian Institute of Sport Assessment Achilles-Specific Questionnaire. Data presented as score (95% CI). A significant main effect of time (P = 0.03) was found (Table 3), but the between-group difference was not significant. The ITT analysis yielded similar results.
Table 3.

NPRS values at baseline and follow-up[]

Baseline4 wk8 wk12 wk26 wk52 wk
Exercise5.4 (3.6-7.2)3.8 (2.0-5.6)2.5 (1.0-3.9)3.0 (1.5-4.4)2.1 (1.4-2.8)1 (-0.6-2.6)
Astym4.6 (2.8-6.4)2.3 (1.1-3.5)2.7 (1.1-4.3)1.7 (0.8-2.8)0.8 (-0.2-1.9).67 (-0.6-1.9)

NPRS, numeric pain rating scale.

Data presented as score (95% CI).

NPRS values at baseline and follow-up[] NPRS, numeric pain rating scale. Data presented as score (95% CI).

Additional Care

There was no significant difference (P = 0.53) in the number of subjects who sought additional care after completion of the 12-week study intervention phase. In the exercise group, 1 of 8 subjects sought additional care by the 52-week follow-up compared with 0 subjects in the soft tissue treatment (Astym).

Discussion

In the current study, soft tissue treatment (Astym) plus eccentric exercise was more effective than eccentric exercise at decreasing the severity of AT over a 12-week period, and these differences were maintained at 26- and 52-week follow-up periods. Additionally, a significantly greater number of subjects in the soft tissue treatment (Astym) group obtained a successful outcome. Both groups experienced a statistically significant decrease in pain over the course of the study, but the difference between groups was not statistically significant. These results seem to indicate that soft tissue treatment (Astym) plus eccentric exercise is an effective treatment in the management of insertional AT. One possible explanation for the small difference in NPRS scores despite the large difference in VISA-A scores is that the subjects in the exercise-only group were generally less physically active at the study follow-up points. This is a reasonable assumption based on final VISA-A scores. With this in mind, it is plausible that subjects in the exercise-only group may have been avoiding aggravating activities, thus making their final NPRS scores artificially lower when compared with the more active soft tissue treatment (Astym) group. There are some limitations to the current study that should be considered. First, the sample size was relatively small. While the study was adequately powered for the primary outcome, a larger sample size with multiple treatment sites could improve the generalizability of the results. A second limitation is the difference in contact with a therapist between the 2 groups. The soft tissue treatment (Astym) group was seen in the clinic for up to 12 sessions while subjects in the exercise-only group met with a therapist 1 to 4 times. The potential effect was minimized by contacting subjects in the exercise group 1 time per week by phone. It should also be considered that the eccentric exercise program is commonly performed as a home program only, and subjects in the exercise group actually received more contact than a typical patient receiving this intervention would.

Conclusion

Over a 12-week treatment period, soft tissue treatment (Astym) combined with eccentric exercise resulted in better outcomes than eccentric exercise alone for subjects with insertional AT. This difference was maintained at both 26- and 52-week follow-ups. Both groups experienced a statistically significant decrease in pain over the course of the study, but the difference between groups was not statistically significant.
  38 in total

1.  Comparative reliability and validity of chronic pain intensity measures.

Authors:  M P Jensen; J A Turner; J M Romano; L D Fisher
Journal:  Pain       Date:  1999-11       Impact factor: 6.961

Review 2.  Current concepts review: insertional achilles tendinopathy.

Authors:  Todd A Irwin
Journal:  Foot Ankle Int       Date:  2010-10       Impact factor: 2.827

3.  The victorian institute of sports assessment - achilles questionnaire (visa-a) - a reliable tool for measuring achilles tendinopathy.

Authors:  Jonas Vestergård Iversen; Else Marie Bartels; Henning Langberg
Journal:  Int J Sports Phys Ther       Date:  2012-02

4.  Development of a clinical prediction rule to identify patients with neck pain likely to benefit from thrust joint manipulation to the cervical spine.

Authors:  Emilio J Puentedura; Joshua A Cleland; Merrill R Landers; Paul E Mintken; Adriaan Louw; César Fernández-de-Las-Peñas
Journal:  J Orthop Sports Phys Ther       Date:  2012-05-14       Impact factor: 4.751

5.  The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy.

Authors:  J M Robinson; J L Cook; C Purdam; P J Visentini; J Ross; N Maffulli; J E Taunton; K M Khan
Journal:  Br J Sports Med       Date:  2001-10       Impact factor: 13.800

6.  The clinical diagnosis of subcutaneous tear of the Achilles tendon. A prospective study in 174 patients.

Authors:  N Maffulli
Journal:  Am J Sports Med       Date:  1998 Mar-Apr       Impact factor: 6.202

Review 7.  Achilles tendon injuries in athletes.

Authors:  M Kvist
Journal:  Sports Med       Date:  1994-09       Impact factor: 11.136

Review 8.  Current concepts in the management of tendon disorders.

Authors:  J D Rees; A M Wilson; R L Wolman
Journal:  Rheumatology (Oxford)       Date:  2006-02-20       Impact factor: 7.580

Review 9.  Achilles and patellar tendinopathy: current understanding of pathophysiology and management.

Authors:  Suan Cheng Tan; Otto Chan
Journal:  Disabil Rehabil       Date:  2008       Impact factor: 3.033

10.  Astym treatment vs. eccentric exercise for lateral elbow tendinopathy: a randomized controlled clinical trial.

Authors:  Thomas L Sevier; Caroline W Stegink-Jansen
Journal:  PeerJ       Date:  2015-05-19       Impact factor: 2.984

View more
  15 in total

1.  JOINT MOBILIZATION IN THE MANAGEMENT OF PERSISTENT INSERTIONAL ACHILLES TENDINOPATHY: A CASE REPORT.

Authors:  Dhinu J Jayaseelan; Andrew A Post; John J Mischke; Josiah D Sault
Journal:  Int J Sports Phys Ther       Date:  2017-02

2.  Insertional and mid-substance Achilles tendinopathies: eccentric training is not for everyone - updated evidence of non-surgical management.

Authors:  Jill L Cook; Dimitrios Stasinopoulos; Jean-Michel Brismée
Journal:  J Man Manip Ther       Date:  2018-06-01

Review 3.  Current Concepts Review Update: Insertional Achilles Tendinopathy.

Authors:  Ruth L Chimenti; Chris C Cychosz; Mederic M Hall; Phinit Phisitkul
Journal:  Foot Ankle Int       Date:  2017-08-08       Impact factor: 2.827

4.  Instrument-Assisted Soft Tissue Mobilization: A Systematic Review and Effect-Size Analysis.

Authors:  Cristina B Seffrin; Nicole M Cattano; Melissa A Reed; Alison M Gardiner-Shires
Journal:  J Athl Train       Date:  2019-07-19       Impact factor: 2.860

5.  ICON 2020-International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy.

Authors:  Karin Grävare Silbernagel; Peter Malliaras; Robert-Jan de Vos; Shawn Hanlon; Mitchel Molenaar; Håkan Alfredson; Inge van den Akker-Scheek; Jarrod Antflick; Mathijs van Ark; Kenneth Färnqvist; Zubair Haleem; Jean-Francois Kaux; Paul Kirwan; Bhavesh Kumar; Trevor Lewis; Adrian Mallows; Lorenzo Masci; Dylan Morrissey; Myles Murphy; Richard Newsham-West; Richard Norris; Seth O'Neill; Koen Peers; Igor Sancho; Kayla Seymore; Patrick Vallance; Arco van der Vlist; Bill Vicenzino
Journal:  Sports Med       Date:  2021-11-19       Impact factor: 11.136

6.  Conservative Management of Knee Pain Associated With a Benign Femoral Osteochondroma in a Youth Athlete: A Case Report.

Authors:  Morgan R Price
Journal:  J Chiropr Med       Date:  2022-03-03

Review 7.  Nonsurgical Treatment Options for Insertional Achilles Tendinopathy.

Authors:  Connor P Dilger; Ruth L Chimenti
Journal:  Foot Ankle Clin       Date:  2019-05-22       Impact factor: 1.653

8.  INSTRUMENT ASSISTED SOFT-TISSUE MOBILIZATION: A COMMENTARY ON CLINICAL PRACTICE GUIDELINES FOR REHABILITATION PROFESSIONALS.

Authors:  Scott W Cheatham; Russell Baker; Ethan Kreiswirth
Journal:  Int J Sports Phys Ther       Date:  2019-07

9.  Astym® therapy improves FOTO® outcomes for patients with musculoskeletal disorders: an observational study.

Authors:  Leah S Harris; Suzanne Freeman; Ying-Chih Wang
Journal:  Ann Transl Med       Date:  2019-10

Review 10.  Nonoperative treatment of insertional Achilles tendinopathy: a systematic review.

Authors:  Xiaosong Zhi; Xinyuan Liu; Jing Han; Yang Xiang; Helin Wu; Shijun Wei; Feng Xu
Journal:  J Orthop Surg Res       Date:  2021-03-30       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.